Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...

Sulodexide is under clinical development by Alfasigma and currently in Phase III for Venous Thromboembolism. According to GlobalData, Phase III drugs for Venous Thromboembolism have a 60% phase ...

Velopharyngeal insufficiency (VPI) is a speech condition that occurs when the soft palate and throat are unable to create a seal while speaking. This causes nasal speech that can make the speaker ...

Professor Ben Cowie warned the region of Victoria that cases of Buruli ulcer “remained high” across the state, with a recent increase in infections linked to the suburb of Ascot Vale.

Health experts are warning of the potential spread of a flesh-eating ulcer, after a surge in cases across Victoria and concerns a NSW holiday beach town is the next hotspot. Warning: This story ...

Health officials have warned "everyone is at risk" after a sickening flesh-eating ulcer disease started to spread in a UK holiday hotspot. Two cases of Buruli ulcer have been confirmed in Batemans ...

The event will focus on EscharEx, an innovative biologic drug in late-stage development for chronic wound debridement, specifically targeting Venous Leg Ulcers (VLUs). The event will feature three ...

Chronic venous insufficiency manifests as a spectrum of signs and symptoms, including varicose veins, leg swelling, skin changes, and leg ulcers. The condition is caused primarily by venous ...

Add articles to your saved list and come back to them any time. A flesh-eating ulcer has taken root in a NSW holiday hotspot and poses a significant risk of spreading to Sydney. Batemans Bay on ...